Navigation Links
Milestone Scientific to Exhibit at the Chicago Dental Society's 143rd Midwinter Meeting
Date:2/15/2008

p>About the Chicago Dental Society

The Chicago Dental Society was organized in 1864 and incorporated in 1878. The objective of the Chicago Dental Society is to encourage the improvement of the health of the public, to promote the art and science of dentistry and to represent the interest of the members of the profession and the public that it serves. CDS memberships cover Cook, Lake and DuPage counties and includes approximately 4,100 members. For more information about the CDS, visit their Web site at http://www.cds.org/.

About Milestone Scientific Inc.

Headquartered in Livingston, New Jersey, Milestone Scientific is engaged in pioneering proprietary, highly innovative technological solutions for the medical and dental markets. Central to the Company's IP platform and product development strategy is its patented CompuFlo(TM) technology for the improved and painless delivery of local anesthetic. Specifically, CompuFlo is a computer-controlled, pressure sensitive infusion, perfusion, suffusion and aspiration technology, which provides real-time readouts of pressures, fluid densities and flow rates, enabling the advanced delivery and removal of a wide array of fluids. The Single Tooth Anesthesia (STA(TM)) computer-controlled local anesthesia delivery system which uses this technology provides dentists with audible and visual signals as to in-tissue pressure. Milestone's existing painless injection systems are currently sold in 25 countries. For more information on these and other innovative Milestone products, please visit the Company's web site found at http://www.milesci.com.

Safe Harbor Statement

This press release contains forward-looking statements regarding the timing and financial impact of the Milestone's ability to implement its business plan, expected revenues and future success. These statements involve a number of risks and
'/>"/>

SOURCE Milestone Scientific Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Milestone Scientific Appoints Dental Industry Veteran Scott Mahnken as New Director of Marketing
2. Vendormate Storms into 2008 with Major Milestones for Hospital Vendor Compliance
3. Tethys Bioscience Hits Key Milestones With Series C Funding, Opening of CLIA Laboratory
4. TyraTech Achieves Insecticide Development and Financial Milestones With Partner Arysta LifeScience
5. Transition Therapeutics Announces Milestone Payment from Elan
6. Joe Martin Appointed CEO of Milestone Scientific and New Executive Member of the Board of Directors
7. IBM reports milestone in silicon nanophotonics
8. Medarex to Receive Milestone Payment for Submission of Regulatory Applications Requesting Approval of Ustekinumab (CNTO 1275) for Treatment of Psoriasis
9. Bavarian Nordic Receives $25 Million Milestone Payment From HHS for Fulfilling Contract Milestones
10. Exelixis to Receive Milestone Payment From Bristol-Myers Squibb for Achievement of Liver X Receptor Agonist Development Milestone
11. Marlo Thomas and St. Jude Childrens Research Hospital(R) Announce Hitting The 50-Partner Milestone as They Kick Off the Fourth Annual Thanks and Giving(R) Campaign Which Asks America to Support St. Jude While Shopping This Holiday Season

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/8/2009)...lutions is pleased to announce that it has been su...or ReSound who recently received an award on the $...ward includes not only the Veterans Administration...eral agencies. , New York...ns is pleased to announce that it has been success...
(Date:11/8/2009)...battle is won," said Dr. Charmaine Yoest. ,, W...vote of 240-194, the Stupak-Ellsworth-Pitts-Kaptur...bortion mandates and funding in HR 3962 passed on ...ction President and CEO Dr. Charmaine Yoest said, ...e pro-life Americans across this country who have ...
(Date:11/8/2009)...SNewswire/ -- The following was released today by ...ta Nex. ,, Mr. Terry and his associates from a...-killing by abortion out of any health care bill f...t first step to victory -- a touchdown in the firs...f us. Our rejoicing must be tempered by reality. T...
(Date:11/7/2009)...SNewswire/ -- Karen Ignagni, President and CEO of ...the following statement today on House passage of ...mprehensive health care reform, and we have contri...verhaul of how health insurance is provided. Earli...mination of pre-existing condition exclusions, no ...
(Date:11/7/2009)...Calling this a "defining moment" for the American ...mes Rohack, M.D., today addressed medical students...specialty societies at the opening of the AMA,s se...em reform will top the agenda. ,, (Logo: http... ) ,, "Over the next 72 hours, this AMA House o...
Breaking Medicine News(10 mins):Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 2Health News:3D Global Solutions Selected to Program Manage GN ReSound/VA Digital Hearing Aid Contract 3Health News:Americans United for Life Action Comments on Passage of Pro-Life Amendment: Bipartisan Pro-life Majority Reflects the Will of the American People 2Health News:AHIP Statement on House Passage of H.R. 3962 2Health News:AMA President Kicks Off AMA Meeting Focused on Health Reform 2
...arhers have found from a long-term study that men ...s more likely to eventually develop Parkinson's di... of Biostatistics and Statistics at the University...tipation is defined as less than one bowel movemen...
...sure to sunlight may increase the risk of developi... a cloudy or opaque area in the normally transpare...vents light rays from passing through the lens and...d people who were exposed to high levels of sunlig...
...of the leading pharmaceutical industries, Ranbaxy ...-market Ranbaxy’s once-a-day formulation of Ciprof...g Controller General of India’s (DCGIs) approval f... around Rs 310 crore. // Ciprofloxacin is the...
...ing men are at greater risk of developing heart di...earchers.Their findings were published in the Arch...ng relationship" between coronary heart disease an...9% increased chance of getting heart disease. Comp...
...he biggest breakthrough, the incidence of the dise...ation of drugs that keeps blood pressure in check.... years in many countries showed that strokes were ... and heart attacks and consequently deaths. The dr...
...e are many grueling and expensive options to explo... of it being Acupuncture. According to an art... are particularly favour acupuncture because they ...s, hundreds are lost with each menstrual cycle and...
Other Medicine News:
(Date:11/6/2009)...ANGLE PARK, N.C., Nov. 6 Chimerix,...y-available antiviral therapeutics to address life...velopment of the company,s lead antiviral compound...nd the Global Health Security Initiative (GHSI). ...eveloped for the treatment of smallpox, as well as...
(Date:11/6/2009)...ov. 6 California American Water ha...rugs Down the Drain" week for its San Diego County...ored by public and private agencies alike toward t...tion in our source water supplies. ,, Californi...encouraged to drop off expired or unwanted pharmac...
(Date:11/5/2009)...rio, Nov. 5 Helix BioPha...ed today that its Phase II trial of Topical Interf...ts (AGW) has completed patient enrollment, with th...rial. ,, The double-blind and placebo-controlle...n Germany and Sweden. Patients participating in t...
Breaking Medicine Technology:Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 2Chimerix Updates the World Health Organization and the Global Health Security Initiative on Development of CMX001 as a Broad-Spectrum Therapeutic for Smallpox 3California American Water Celebrates 'No Drugs Down the Drain' Week in San Diego 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 2Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 3Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 4Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 5Helix BioPharma Corp. Completes Enrollment in Its Phase II Trial of Topical Interferon Alpha-2b in Patients With Ano-Genital Warts 6Letter to Shareholders From Imagenetix Inc President CEO William Spencer 4902 1Letter to Shareholders From Imagenetix Inc President CEO William Spencer 4902 2Letter to Shareholders From Imagenetix Inc President CEO William Spencer 4902 3Letter to Shareholders From Imagenetix Inc President CEO William Spencer 4902 4Letter to Shareholders From Imagenetix Inc President CEO William Spencer 4902 5A better test to detect DNA for diagnosing diease investigating crimes 55405 1Rutgers Camden developing enzyme function database 9702 1Rutgers Camden developing enzyme function database 9702 2
... FRANCISCO, Calif., July 9 Portola,Pharmaceutical...cused on,the discovery and development of novel th...eases, announced today that is has raised $60 mill...be used primarily to advance,Portola,s two lead an...RT060128, which the company is developing as best-...
... FRANCISCO, July 9 Cerimon Pharmaceuticals,Inc., ...of-concept study of,Simulect(R) (basiliximab) for ...and potentially sight-threatening inflammation of ...ntrolled study will evaluate the,safety and effica...ts.,During the study, patients will undergo taperi...
Other Medicine Technology:Portola Completes $60 Million Financing to Advance Its Therapeutic Programs 2Portola Completes $60 Million Financing to Advance Its Therapeutic Programs 3Cerimon Pharmaceuticals Initiates Phase II Study to Evaluate Simulect(R) (Basiliximab) for Noninfectious Uveitis 2
AxSYM
ADVIA Centaur Immunoassay System
...linical system combines market-leading chemistry a...y testing capabilities, innovative data management...m. After tests are performed, critical results are...nce. If reflex tests are necessary based on user d...
Miltex frazier ferguson suction tubes
Medicine Products: